Ovid Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	20.61	26.3	27.04	44.87	187.8	72.03
Short-Term Investments	4.99	26.77	78.79	84.13	-	-
Cash & Short-Term Investments	25.6	53.08	105.83	129	187.8	72.03
Cash Growth	-59.17%	-49.85%	-17.96%	-31.31%	160.71%	-6.13%
Other Receivables	-	-	-	-	-	0.14
Receivables	-	-	-	-	-	0.14
Prepaid Expenses	3.22	2.87	3.76	2.38	2.68	2.67
Other Current Assets	-	-	0	-	-	-
Total Current Assets	28.82	55.94	109.6	131.38	190.48	74.84
Property, Plant & Equipment	12.19	13.23	14.66	16.07	0.24	0.14
Long-Term Investments	20.91	20.97	17.63	5.62	1.63	-
Other Intangible Assets	-	0.09	0.2	0.22	0.26	0.32
Other Long-Term Assets	1.93	1.93	1.94	1.97	1.93	0.63
Total Assets	63.85	92.17	144.03	155.27	194.54	75.93
Accounts Payable	1.71	3.19	3.7	1.95	7.13	5.45
Accrued Expenses	2.96	5.99	6.52	4.5	7.67	12.03
Current Portion of Leases	1.41	1.34	1.25	0.53	-	-
Current Unearned Revenue	0.72	-	-	-	-	2.21
Other Current Liabilities	-	0	-	-	-	2.37
Total Current Liabilities	6.8	10.52	11.47	6.99	14.8	22.06
Long-Term Leases	12.35	13.42	14.76	16	-	-
Long-Term Unearned Revenue	-	-	-	-	-	10.17
Other Long-Term Liabilities	-	-	30	-	-	0.06
Total Liabilities	19.15	23.94	56.23	22.99	14.8	32.29
Common Stock	0.07	0.07	0.07	0.07	0.07	0.07
Additional Paid-In Capital	376.13	372.49	365.59	357.77	351.03	337.76
Retained Earnings	-331.38	-304.3	-277.87	-225.53	-171.36	-294.19
Comprehensive Income & Other	-0.13	-0.04	-	-0.04	-	-
Total Common Equity	44.7	68.23	87.8	132.27	179.75	43.63
Shareholders' Equity	44.7	68.23	87.8	132.27	179.75	43.63
Total Liabilities & Equity	63.85	92.17	144.03	155.27	194.54	75.93
Total Debt	13.76	14.76	16	16.54	-	-
Net Cash (Debt)	11.84	38.32	89.83	112.47	187.8	72.03
Net Cash Growth	-75.14%	-57.34%	-20.13%	-40.11%	160.71%	-6.13%
Net Cash Per Share	0.17	0.54	1.27	1.60	2.76	1.23
Filing Date Shares Outstanding	71.21	71.08	70.71	70.49	70.37	65.75
Total Common Shares Outstanding	71.15	71.01	70.69	70.47	70.36	65.74
Working Capital	22.03	45.42	98.13	124.39	175.68	52.78
Book Value Per Share	0.63	0.96	1.24	1.88	2.55	0.66
Tangible Book Value	44.7	68.13	87.6	132.05	179.49	43.31
Tangible Book Value Per Share	0.63	0.96	1.24	1.87	2.55	0.66
Machinery	1.53	1.53	1.46	1.42	0.5	0.32
Leasehold Improvements	0.31	0.31	0.31	0.31	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.